This real-world study enrolled 171 patients with Type 2 Diabetes Mellitus who received multidisciplinary management at the Diabetes Reversal Clinic. The primary outcome was the remission rate of T2DM, assessed during a follow-up period of more than 24 weeks. Secondary outcomes included changes in fasting blood glucose, 2-hour postprandial blood glucose, HbA1c, blood lipids, and body composition. No adverse events, serious adverse events, discontinuations, or specific tolerability data were reported in the study.
Analysis identified several independent predictors of T2DM remission. Older age was associated with remission (OR = 0.93; 95% CI: 0.89-0.97, P = 0.002). The type of medications at baseline was also an independent predictor (OR = 0.45; 95% CI: 0.26-0.77, P = 0.004). Higher baseline fasting blood glucose levels correlated with lower remission likelihood (OR = 0.64; 95% CI: 0.46-0.89, P = 0.008). Conversely, greater weight loss magnitude was positively associated with remission (OR = 1.15; 95% CI: 1.01-1.31, P = 0.038).
Key limitations include the single-arm observational design, which precludes the establishment of causality. The study phase was not reported, and funding or conflicts of interest were not disclosed. Due to the lack of a control group, the specific contribution of the multidisciplinary management to the observed remission rate remains uncertain. Clinicians should interpret these results with caution and await data from prospective controlled trials before altering standard practice based solely on these findings.
View Original Abstract ↓
ObjectiveTo evaluate the effects of multidisciplinary management in the Diabetes Reversal Clinic on the remission of type 2 diabetes mellitus (T2DM), and explore the predictive factors for remission of diabetes.MethodsThis was a real-world, single-arm observational study. Patients with T2DM who received remission-oriented treatment at the Diabetes Reversal Clinic and followed up regularly for more than 24 weeks were included. The primary outcome was the remission rate of T2DM, and the secondary outcomes were changes in fasting blood glucose (FBG), 2-hour postprandial blood glucose, HbA1c, blood lipids, and body composition. Differences in clinical characteristics between the remission and non-remission groups were analyzed. The multivariate logistic regression analysis was performed to screen predictive factors.ResultsThe remission rate was 29.24% (50/171) after multidisciplinary management in the Diabetes Reversal Clinic. The remission group was younger, had a shorter duration of diabetes, used fewer types of medications at baseline, had a lower FBG and HbA1c, a higher β-cell function index HOMA-β, and a lower triglyceride level. The multivariate logistic regression analysis revealed that age (OR = 0.93, 95% CI: 0.89-0.97, P = 0.002), type of medications at baseline (OR = 0.45, 95% CI: 0.26-0.77, P = 0.004), baseline FBG (OR = 0.64, 95% CI: 0.46-0.89, P = 0.008), and weight loss magnitude (OR = 1.15, 95% CI: 1.01-1.31, P = 0.038) were independent predictors of T2DM remission.ConclusionIn this real-world study, the remission rate of T2DM patients who visited the Diabetes Reversal Clinic for more than 24 weeks was 29.24% (50/171). Younger age, shorter disease duration, fewer baseline medications, lower FBG and HbA1c, higher HOMA-β, lower triglycerides, and greater weight loss were associated with remission of T2DM. Among them, age, baseline medication type, baseline FBG, and weight loss were identified as factors independently associated with remission. However, due to the single-arm observational design, causality cannot be established, and further prospective controlled trials are required to confirm these findings.